Unique Plan Description: remdesivir
Plan Selection Display: remdesivir
PlanType: Medical                                 
Version: 1          
Begin Effective Date: 2020-05-29 13:42:59
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2024-05-21 12:27:19
Available at all facilities: Yes

remdesivir
Laboratory
	CBC with Diff
		T+1;0400, Routine, Q24H 5 Day(s), spec type = Blood
			Comment: while on therapy
	Comprehensive Metabolic Panel
		T+1;0400, Routine, Q24H 5 Day(s), spec type = Blood
			Comment: while on therapy
Medications
				REMDESIVIR GUIDELINES FOR USE- Age > 18- Confirmed PCR for COVID 19 with reliable history of onset of symptoms within the last 2 weeks- Exclude other causes leading to presentation (ie PE, CHF)- Recommend for use in patients with reasonable func(NOTE)*
	remdesivir
		200 mg, INT, IVPB, Once, COVID-19, T;N, Infuse Over 1 hr
		100 mg, INT, IVPB, Q24H, COVID-19, T+1;N, 4 Dose(s)/Time(s), Infuse Over 1 hr

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase